
BPC-157 + TB-500 — the most-studied tissue repair pair.
A protocol built around BPC-157 and TB-500 — complementary peptides that together cover the localized and systemic dimensions of tissue repair. BPC-157 works at the injury site, supporting angiogenesis and gut and connective-tissue integrity via VEGF and nitric-oxide signaling. TB-500 works systemically, promoting cell migration and anti-inflammatory repair across multiple tissue types. Dispensed as a single combination vial under physician supervision.
Who it's for: Active adults managing chronic injuries, post-surgical recovery, gut health, or persistent inflammation.
RECOVER pairs 2 compounds:
BPC-157 (pentadecapeptide)
Synthetic pentadecapeptide derived from a gastric protein. Preclinical research suggests it promotes angiogenesis via VEGF signaling, modulates nitric-oxide pathways, and supports cytoprotection in the GI lining and connective tissue.
Used for
TB-500 (Thymosin Beta-4 fragment)
Synthetic analog of Thymosin Beta-4, involved in actin regulation and cell migration. Research suggests it supports systemic wound healing, soft-tissue recovery, and anti-inflammatory signaling across multiple tissue systems.
Used for
The following reflects areas of interest commonly reported by members and studied in the clinical literature. Results depend on individual health status, labs, and physician-directed care. Nothing below constitutes a treatment claim.
BPC-157 works at the site of injury while TB-500 signals repair body-wide — together covering both dimensions of recovery for adults managing chronic training loads or returning from injury.
The pair supports angiogenesis and the healing cascades that speed return to function after orthopedic or soft-tissue procedures.
Both peptides modulate inflammatory pathways without systemic immunosuppression — a physician-supervised option outside the NSAID profile.
RECOVER is prescribed and monitored against labs. The Halftime Baseline panel ($249, separate onboarding deliverable) covers the relevant markers below.
RECOVER is most commonly chosen by members whose primary intent is one of:
Available at every tier
The Halftime Baseline lab panel ($249) is a separate onboarding deliverable, available at any tier.
Join the waitlistLaunching July 1, 2026
All prescriptions require physician evaluation. Compounded medications are not FDA-approved. Individual results vary. This is not medical advice.